Weisblum Eric 4
4 · Silo Pharma, Inc. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Weisblum Eric
DirectorPres, Chief Compliance Officer
Transactions
- Purchase
Common Stock
2025-11-19$0.41/sh+4,500$1,823→ 209,932 total - Purchase
Common Stock
2025-11-18$0.40/sh+7,500$3,025→ 205,432 total
Footnotes (2)
- [F1]This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 18, 2025 at prices ranging from $0.4000 to $0.4050. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 19, 2025 at prices ranging from $0.3975 to $0.4100. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.